https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-04-20 / JCI Insight 2017 Apr;2(8)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-04-20 / JCI Insight 2017 Apr;2(8)2017-04-20 00:00:002019-02-15 08:49:48Twelve-year survival and immune correlates in dendritic cell-vaccinated melanoma patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-04-18 / Oncotarget 2017 Apr;8(16):27252-27262
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-04-18 / Oncotarget 2017 Apr;8(16):27252-272622017-04-18 00:00:002019-02-15 08:39:10Combination therapy with dendritic cells and lenalidomide is an effective approach to enhance antitumor immunity in a mouse colon cancer model
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-04-18 / 2017 May;39(5):884-893
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-04-18 / 2017 May;39(5):884-8932017-04-18 00:00:002017-04-18 00:00:00Immune Modulation by Vitamin D: Special Emphasis on Its Role in Prevention and Treatment of Cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-04-15 / Clin. Cancer Res. 2017 04;23(8):1898-1909
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-04-15 / Clin. Cancer Res. 2017 04;23(8):1898-19092017-04-15 00:00:002019-02-15 08:47:32Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-04-14 / Cancer 2017 Aug;123(16):3061-3072
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-04-14 / Cancer 2017 Aug;123(16):3061-30722017-04-14 00:00:002019-02-15 08:32:48Immune responses and long-term disease recurrence status after telomerase-based dendritic cell immunotherapy in patients with acute myeloid leukemia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-04-13 / Oncotarget 2017 Aug;8(32):52651-52664
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-04-13 / Oncotarget 2017 Aug;8(32):52651-526642017-04-13 00:00:002017-04-13 00:00:00Combination treatment with transarterial chemoembolization, radiotherapy, and hyperthermia (CERT) for hepatocellular carcinoma with portal vein tumor thrombosis: Final results of a prospective phase II trial
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-04-12 / Onco Targets Ther 2017;10:2097-2106
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-04-12 / Onco Targets Ther 2017;10:2097-21062017-04-12 00:00:002019-02-15 08:34:49Targeting the PD-1 pathway in pediatric solid tumors and brain tumors
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-04-07 / J Hematol Oncol 2017 04;10(1):82
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-04-07 / J Hematol Oncol 2017 04;10(1):822017-04-07 00:00:002019-02-15 08:52:39Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-04-07 / Breast 2017 Jun;33:159-165
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-04-07 / Breast 2017 Jun;33:159-1652017-04-07 00:00:002017-04-07 00:00:00Reirradiation for locally recurrent breast cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-04-01 / Cancer Control 2017 Apr;24(2):180-186
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-04-01 / Cancer Control 2017 Apr;24(2):180-1862017-04-01 00:00:002019-02-15 08:36:12Assessing Response of High-Grade Gliomas to Immune Checkpoint Inhibitors
